Press Hits

May 7, 2013- The Daily Herald: St. Marteen exploring options to reduce HIV medicines price (links to

Actions in St Maarten


"In some countries, including Sint Maarten and Curacao, the high costs of ARV drugs have been identified as a major obstacle to access to treatment. Our research conducted in 2008 showed that ARV prices on these islands are up to 17 times higher than the international reference prices. Without sustained access to antiretroviral drugs, the challenge of treatment cannot be met- and the ravage of the epidemic will continue. Dokters van de Wereld fights for the right to health of all human beings, especially the most vulnerable. This includes the right to have access to affordable HIV treatment. Therefore, we support this global access campaign initiated by health groups around the world."

-- Melissa Diaz, MD, MIH, Secretary of the board, Dokters van de Wereld, the Netherlands

On the Caribbean island of St. Maarten, Kaletra costs 7,644 NAf (~$4,361) per person per year (ppy). Many people living with HIV in St. Maarten are migrants, and much less economically advantaged than their Dutch counterparts. 

The St. Maarten AIDS Foundation sent a letter to Abbott requesting an open license that would enable St. Maarten to import affordable generics.

Copy of St. Maarten AIDS Foundation letter to Abbott Laboratories requesting an open license (11/10/2011)




Return to the Kaletra Campaign Homepage

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.


To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.